A B S T R A C T A sensitive and simple procedure for the detection and quantitation of soluble complement (C) -fixing immune complexes in sera of patients with various disease states has been developed by utilizing C receptors on Raji cells. These cells lack membrane-bound immunoglobulin but have receptors for IgG Fc, C3b, C3d, and possibly other C proteins. Uptake experiments showed that both aggregated human gamma globulin (AHG) and 7S IgG bound to receptors for IgG Fc; however, AHG reacted with C bound to cells only via receptors for C and this binding was much more efficient than via IgG Fc receptors. AHG was used as an in vitro model of human immune complexes and its uptake by Raji cells was quantitated by 'I-radiolabeled antihuman IgG. The limit of sensitivity of this test was 6 ,ig AHG/ ml serum. The ability of Raji cells to detect AHG in serum depended on the amount of radioactive antibody used and the size of aggregates. The presence of an excess of C somewhat inhibited binding of AHG containing C to Raji cells.
INTRODUCTION
Immune complexes appear to be one of the most important mechanisms by which immunologic tissue injury is produced. Their phlogogenic and immunopathogenic roles have been well established in experimental animal models. The experiments with serum sickness are the most clear-cut examples (1) . With the refinement of the necessary techniques, pathogenic immune complexes are increasingly recognized as the cause of many disorders in animals and humans (2) . Exogenous as well as endogenous antigens can trigger pathogenic immune responses resulting in deposition of immune complexes in tissues (3) . The glomerular filter, arterial wall, and choroid plexus are the sites where immune complexes most commonly deposit (4) .
With immunofluorescence and electron microscopy, immune complexes are seen fixed in tissues (3, 5) . In addition, antibodies can be eluted from the diseased tissues (6) . More recently, it has become possible to detect immune complexes directly in the circulation with a variety of new procedures. Such methods include precipitation with C1q in agarose gels (7) , precipitation with monoclonal rheumatoid factor (8) , precipitation with polyethylene glycol (PEG)1 (9) and its modification-selective precipitation by PEG of 'I-Clq bound to complexes- (10) , agglutination of latex particles (11) , competitive inhibition of uptake of radioactive complexes by guinea pig peritoneal macrophages (12) , microcomplement consumption (13) , inhibition of antibody-mediated cytotoxicity (14) , platelet aggregation (15) , cryoprecipitation (16) , alternate appearance in the circulation of antigen or antibody (17, 18) , and analytical ultracentrifugation (19) . lAbbreviations used in this paper: AHG, aggregated human IgG; BSA, bovine serum albumin; C, complement; DHF, dengue hemorrhagic fever; FITC, fluorescein isothiocyanate; HB.Ag, hepatitis B surface antigen; HSA, human serum albumin; MBIg, membrane-bound immunoglobulin; MEM, minimal essential medium; MEM-HSA, minimal essential medium containing 1% human serum albumin; NHS, normal human serum; PBS, phosphate-buffered saline; PEG, polyethylene glycol; SGOT, serum glutamic oxaloacetic acid transaminase; SLE, systemic lupus erythematosus; SSPE, subacute sclerosing panencephalitis.
The Journal of Clinical Investigation Volume 57 January 1976 [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] Raji cells, a human lymphoblastoid cell line with B cell characteristics, may be used as in vitro detectors of circulating immune complexes. These cells lack membrane-bound immunoglobulin (MBIg), but have receptors for IgG Fc, C3b, C3d (20) , and Clq (21) . Recently, we developed an immunofluorescence test in which complement (C)-fixing immune complexes in sera were detected by the use of C receptors on Raj i cells (22) . However, this test had the disadvantages of not being quantitative and of requiring blockage of the IgG Fc receptors before use with human sera, to avoid a positive background reaction due to the binding of 7S IgG. We now report a modification of this method in which immune complexes in human sera have been demonstrated and quantitated by measuring uptake of radioactive antibody by IgG in the immune complexes bound to cells.
METHODS
Lymphoblastoid cell line. Raji cells, which are derived from Burkitt's lymphoma (23) , were cultured in Eagle's minimal essential medium (MEM), as has been described (22) . Cell viability was determined by trypan blue exclusion. Preliminary experiments have shown that receptors for IgG Fc, C3b, and C3d on these cells are expressed equally well throughout the cell cycle, as evidenced by uptake experiments with radiolabeled human IgG and the fragments of C3 on synchronized cell cultures. However, cells used in these experiments were always obtained 72 h after initiation of the cultures.
Preparation of aggregated human gamma globulin (AHG) sand monomeric IgG. Human IgG was obtained from Cohn fraction II after fractionation on a DEAE-52 cellulose column with a 0.01 M phosphate buffer, pH 7.3. Human IgG in phosphate-buffered saline (PBS) was freed from aggregates by centrifugation at 150,000 g for 90 min; the upper third of the supernate (deaggregated or 7S IgG) was removed, and the protein concentration was determined by an automated micro-Kjeldahl method (24) . The 7S IgG was placed into samples of 0.1 ml (6.5 mg/ml), and stored at -700C. AHG was prepared after heating a sample of 7S IgG in a waterbath at 63°C for 30 min.
Antisera. Antiserum to human IgG was prepared in rabbits and the IgG fraction of this antiserum was isolated on a DEAE-52 column as above. Antiserum to human C3 (25) and antiserum to hepatitis B surface antigen (HB.Ag) were prepared in rabbits. The rabbit anti-HB.-Ag serum was conjugated with fluorescein isothiocyanate (FITC) (26) . Antiserum (27) . The specific activity of the "2I-rabbit anti-human IgG (1 mg/ml) was 0.2 ,uCi cpm/jtg protein.
Sucrose density gradient ultracentrifugation. AHG was fractionated on a linear 10-37%o sucrose density gradient in PBS, pH 72, formed in 5-ml cellulose nitrate tubes. The gradients were equilibrated to 4°C before the sample (300 ,ul of AHG in PBS, 3.5 mg/ml) was applied. Ultracentrifugation was performed in an SW 50.1 rotor for 5 h at 100,000 g and 4°C (Beckman Instruments, Inc., Spinco Div., Palo Alto, Calif. Effect of the aggregates' size on their detection by Raji ceUs. Since large aggregates of IgG fix C better than small ones (7, 30, 31) , and large aggregates or immune complexes made near equivalence bind to C receptors better than smaller aggregates or immune complexes made at large antigen excess (22, 32) , it was important to test the Raji cells' ability to detect aggregates of different sizes. Uptake of radioactive antibody by Raji cells incubated with NHS alone and with NHS containing unfractionated AHG or aggregates of defined sizes is compared in Fig. 4 . It is evident that uptake of radioactive antibody was directly related to the size of aggregates. With the same amounts of 35S-95S AHG and unfractionated AHG, cells took up comparable amounts of radioactive antibody. However, with AHG of 34S-19S and 18S-11S, the cells took up approximately one half to one third the radioactive antibody taken up after incubation with serum containing comparable amounts of unfractionated AHG (Fig. 4) . Therefore, whereas the sensitivity of the Raji cells in detecting unfractionated AHG in serum was approximately 6 Ag/ml, with 34S-19S AHG it dropped to 25 Mg/ml and with 18S-11S to 50 Mg/ml.
The effect of excess C on the binding of AHG with fixed C to Raji cells' C receptors. Receptors for C3b on Raji cells are the same or closely associated with the receptors for C3 (33) , and immune complexes or AHG reacted with C bind to cells via both C3-C3b and C3d receptors (20) . Since free C3 may compete with immune complex-bound C3b for the C3-C3b receptor sites, the effect of excess C on the binding of AHG with fixed C to Raj i cells was assessed. In Fig. 5 (Fig. 6 ). This inhibition was not greater than 50% of the optimal uptake, and even with a large excess of C did not descend to the low uptake observed with AHG without fixed C (Fig. 6 ). The results showed that an excess of C had some inhibitory effect on the binding of complexes with fixed C. (Table II) with a mean value of 55-68 jg AHG eq/ml serum. Results from the Raji cell assay of sera from patients with acute hepatitis and HB.-Ag obtained at the acute and Fig. 9 illustrates the course of the disease and the results of the Raji cell test in one of these patients (Ham). The correlation is striking between clear-cut flare of SLE (fever, pleuritis), C'Hm depression, presence of antibodies to DNA, and positive results by the Raji cell radioimmune assay. All indices rapidly returned toward normal after prednisone treatment began. Sera from patients with DHF, a group B arthropodborne virus infection (39) , were also tested for immune complexes (Table VII) . Circulating immune complexes were found in all grades of the disease (39) with mean values of 58-83 .g AHG eq/ml.
Since sera from hypocomplementemic patients may not have had enough C to render immune complexes detectable by C receptors, hypocomplementemic sera from SLE patients positive in the Raji cell assay and from patients with idiopathic vasculitis negative for immune complexes were supplemented with NHS as a C source. Since it has been suggested that immune complexes, possibly made up of tumor antigens and antibodies, are present in the sera of humans and animals with tumors (40) (41) (42) (43) (44) (45) (46) (47) (48) , sera of patients with various types of malignancies were assayed with the Raji cell test (Table  VIII) . Approximately one third of these patients had circulating complexes, and sera from persons with lymphoid tumors generally had more complexes than persons with solid tumors. When five positive sera were fractionated in a sucrose gradient and the positions of C3 and IgG were analyzed, they were found to contain heavy peaks of C3 and IgG, as opposed to control NHS and sera from cancer patients who were negative for immune complexes.
DISCUSSION
Raji cells were used in a radioimmune assay for the detection of immune complexes. In this assay, uptake of radioactive anti-human IgG by the cells previously incubated with sera of patients with various disorders was used to identify and quantitate circulating immune complexes. The Raji cell radioimmune assay described here is based on the ability of these cells to bind human IgG much more efficiently when it is complexed with an antigen or aggregated and has fixed C than when it is in its monomeric form. In fact, uptake experiments showed that approximately eight times more molecules of IgG bind via C receptors than via IgG Fc receptors. The enhanced binding to Raji cells of C-containing AHG or, as shown in a previous study (22) of immune complexes made in vitro, has been attributed either to the presence of more C receptors than IgG Fc receptors or to the higher binding affinity of C receptors than IgG Fc receptors for their ligand molecules. Another possibility is that complexes containing C have more C3 than complexes without C have IgG Fc sites, and therefore bind better to cells (20, 22) .
We demonstrated earlier that immune complexes containing C bind to Raji cells only via C receptors and that these receptors are distinct from the IgG Fc receptors (20) . Therefore, when a serum containing C-fixing complexes of the IgG variety is added to Raji cells, two types of IgG binding occur. One is mediated via IgG Fc receptors and binds the uncomplexed monomeric IgG, and the other is mediated via C receptors and binds complexed IgG with fixed C. In the absence of immune complexes or in the presence of non-C fixing immune complexes, IgG binds to cells via IgG Fc receptors only. AHG, substituted for immune complexes in vitro, possesses many of their properties (30, 31) and binds to the same Fc and C receptors on cell surfaces (20, 49) .
Since much more IgG binds to Raji cells when it has been altered so it can fix C, the presence of IgG-type immune complexes in human sera can be quantitated by measuring uptake of radioactive antihuman IgG. Our experiments showed that uptake of radioactive antibody was proportional to the amount of AHG bound to cells, which in turn was proportional to the quantity of AHG present in the serum. Since the uptake of radioactive antibody was proportional to the amount of AHG present in the serum, by using the graph of uptake as a standard, the amount of soluble complexes present in test sera could readily be equated to an amount of AHG after correcting for the dilution factor. In the Raji cell radioimmune assay, to differentiate between NHS and serum containing IgG complexes, one must add radioactive antibody in excess of the amount needed to saturate the monomeric IgG bound to cells via Fc receptors. In our experiments with unfractionated AHG and with aggregates of defined sizes, the Raji cell radioimmune assay efficiently identified even 18-11S aggregates. However, it should be noted that when AHG or immune complexes of defined antigen-antibody composition made in vitro are used for obtaining the reference curve, the amount of small complexes present in a serum may be underestimated. That is, serum with small amounts of large immune complexes that activate and fix C well may result in higher binding and antibody uptake than a greater amount of small complexes that activate and fix C less well. Several investigators have shown that activation and fixation of C by immune complexes or AHG are directly related to their size (7, 30, 31) , and we and others have demonstrated that immune complexes made near equivalence bind best to cellular C receptors (22, 32) .
In the course of C activation, C3b binds to immune complexes. Complex-bound C3b is thereafter cleaved by the serum enzyme C3b-inactivator into C3c and C3d, with the d portion remaining on the immune complex (50) . Therefore immune complexes in whole serum may contain C3b, C3d, or both. The receptors for C3 and C3b are the same or closely associated while the C3d receptors are different (20, 33 (51) . Most of the chronic carriers were negative for immune complexes, and this finding is in agreement with their lack of apparent symptoms and with the absence of anticomplementary activity in their serum observed by others (52) . Several reports have confirmed an association between HB.-Ag and polyarteritis (53, 54) . In addition, an immune complex mechanism has been suggested as being responsible for the vasculitis and arthralgia syndrome sometimes seen as a prodrome in patients with acute viral hepatitis (55, 56) . Finally, HB.-Ag, Ig, and C deposits have been found in the glomeruli of few patients with glomerulonephritides (57) .
Sucrose density fractionation of selected positive hepatitis sera showed the presence of a heavy peak of IgG associated with HB.-Ag and C. Oldstone and associates showed that addition of antibody and C to polyoma virus increased its sedimentation rate (58) . In several viral infections C seems to bind to virus-antibody immune complexes in vivo. Evidence that virus in the serum complexes with host Ig and C comes from experiments in which specific precipitation of either Ig or C from the serum removes significant amounts of infectivity, although precipitation of other serum proteins, such as albumin, removes none (59, 60) . These authors, who found that C1 through C3 bind to virusantibody complexes, postulated that some viruses concentrate in or infect certain cells bearing C3 receptors such as B lymphocytes, macrophages, and monocytes (58) . Since Raji cells have large numbers of C receptors, they may concentrate virus-antibody-C complexes present in a serum. In fact, HB8-Ag could be detected by immunofluorescence on the surface of Raji cells incubated with immune complex-containing hepatitis sera.
In patients with SLE, a high degree of correlation was observed between the amount of complexes detected, disease activity, presence of low C levels, and presence of anti-DNA antibodies. Patients with SLE form a spectrum of antibodies that reacts with native or altered autologous antigens (61) . Antibodies directed against a variety of nuclear components are common in these sera (17, 34) , and serum antibody to native DNA accompanying low circulating C levels is generally associated with active lupus nephritis (17, 18, 35, 62) . Furthermore, deposits of DNA, Ig, and C found in the kidneys of these patients resemble those found in experimental immune complex-induced nephritis (18) . However, the nature of the presumed immune complexes detected by the Raji cells in SLE sera remains to be determined.
Sera from patients with SLE may contain antilymphocyte antibodies (36, 37 (66) . In the majority of sera from patients with idiopathic vasculitis, no immune complexes were detected by the Raji cell test. It may be that in these patients, mechanisms other than immune complexes are responsible for C activation and damage of the vascular walls, or that immune complexes, after their formation, are rapidly removed from the circulation and deposited on the arterial walls., Sera as well as cerebrospinal fluids from a limited number of patients with SSPE were also found to contain immune complexes by the Raji cell assay. Measles virus has been implicated in the pathogenesis of this disease (67) , and SSPE sera reportedly contain blocking factors removed by anti-C3 or rheumatoid factor (68) . Furthermore, IgG and C3 deposits have been noted in the vessels of patients with SSPE (69). However, whether the antigen involved in the immune complexes from these sera is indeed the measles virus remains to be determined.
Sera from patients having DHF were found to contain immune complexes; however, the presence of dengue virus antigens in the complexes was not shown. Both the classical and alternative C pathways are known to be activated in these patients' sera (70) . Furthermore, Sobel et al. (71) , using a radiolabeled Clq deviation test, have found Clq-reactive material in these sera as well as a direct correlation between the amount of Clq-reactive material detected and grade of the disease. In our study, patients in the II-III grade of the disease had the highest values for immune complexes. Possibly patients with IV grade of the disease (shock syndrome) contained fewer complexes than patients with II-III grade (hemorrhage, hypotension) because the complexes had deposited on the arterial walls, because large amounts of fluids were administered intravenously, or because of C exhaustion. Future studies of immune complexes in serial bleedings of patients with various grades of DHF may establish a relationship between their immune complexes, C activation, and shock.
Our finding of complexes in the sera of more than one third of unselected cancer patients fits with the suspicion' that in many cancer patients, tumor antigenantibody complexes may circulate and deposit in tissues. Studies conducted by Hellstr6m and associates (72) as well as by others (73) have shown that circulating antibody is demonstrable only when the size of the tumor is very small, i.e., in early stages of tumor growth, after surgical removal, or after a clinical remission. When tumor antigen production is thought to be sufficient to create a condition of antigen excess (large mass of tumor), circulating antibody can no longer be demonstrated (73) . At this stage, however, a serum factor, which contains or is associated with IgG, blocks the cytotoxic effect of lymphocytes against tumor cells in vitro. This factor has been termed "blocking factor", and it is believed to represent tumor antigen-antibody complexes (40) . Other observations further support the concept that tumor-bearing animals and humans may have tumor antigen-antibody complexes fixed in tissues or circulating in blood. Circulating. complexes and deposits of virus-antiviral antibody and C in the renal glomeruli are present in animal models of virus-associated leukemia, lymphoma, and sarcoma (47, 48) , as well as in mice bearing melanoma (41) and neuroblastoma tumors (43) . Moreover, such deposits have occasionally been described in the glomeruli of humans with leukemia, lymphoma, Hodgkin's disease, colon carcinoma (46, 74, 75) , and African Burkitt's lymphoma (45) . Studies are in progress to ascertain the temporal relationship of immune complexes detected by the Raji cell test and activity of the disease in patients with cancer.
The sensitivity of the Raji cell radioimmune assay is significantly greater than that of other tests utilizing Clq for the detection of soluble immune complexes. Whereas Clq precipitation in gel (7) and radiolabeled Clq-PEG precipitation (10) detect AHG at a minimum concentration of approximately 100 og/ml, the Raji cell assay allows the detection of 6 /Ag/ml. However, a Clq deviation test was developed recently, and reportedly was about as sensitive as the Raji cell assay (71) . Nevertheless, the Raji cell test may be morespecific for immune complexes than the tests utilizing Clq, since Clq is known to react not only with immune complexes and AHG but also with non-Ig substances, such as endotoxin and DNA (7, 71 (8) . Microcomplement consumption assays (13) , although sensitive, may give positive results with a variety of materials that can consume C or inhibit C-induced red blood cell lysis, the end point of the assay. Platelet aggregation techniques (15) are plagued by unreproducible platelet preparations, and materials other than immune complexes may cause platelet aggregation. Finally, although reported as a sensitive method of detecting immune complexes in patients with SLE (12), the macrophage inhibition assay requires isolation of macrophages from guinea pigs, the presence of rheumatoid factor interferes with the assay (76) , and finally, its general clinical applicability has not yet been shown.
Apart from the ability of Raji cells to detect immune complexes in vitro, it should be pointed out that these cells, which can concentrate antigen-antibody complexes on their surfaces, may provide the tool by which antigens involved in immune complex diseases will be identified and antisera against them will be raised. Antibodies isolated from the cell-bound complexes as well as antisera raised against the antigen may be of great value in screening humans with suspected immune complex disease.
